GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007210 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.766 |
[BP] GO:0098664 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.766 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 |
12.1454 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.7781 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
11.2552 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
11.1601 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALDH2, ALOX15, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, FUT7, GBA2, HTR2B, HTR2C, PIK3CA, PPARA, PTGS1, PTGS2, TYR, XDH |
10.9379 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.9178 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, BCL2, CA12, CA2, CA7, CDK6, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, F3, FABP3, FABP4, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TNKS, TNKS2, XDH |
10.901 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
10.6158 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, HTR1B, HTR5A, MMP2, MMP9, PIK3CA, PPARA, PTGS2, TYR |
9.88547 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, CNR1, CNR2, DRD2, HTR1B |
9.50988 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
9.31882 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
9.27313 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, CNR1, DRD1, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
9.16806 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, MMP2, MMP9, PIK3CA, PPARA, PTGS2, TYR |
9.05512 |
[BP] GO:0050795 |
None
|
ADORA1, CNR1, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B |
8.68727 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, BCL2, CA2, CA7, CDK6, CNR1, DRD1, DRD2, DRD3, HCAR2, HTR2A, HTR2B, HTR2C, PIK3CB, PTGS2, TNKS, TNKS2 |
8.68374 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, CA2, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB, SIGMAR1 |
8.25533 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2C |
8.25533 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
8.09092 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 |
8.09092 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALDH2, ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
7.98316 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, HTR1B, HTR5A, MMP2, PIK3CA, PPARA, PTGS2, TYR |
7.91141 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, HTR1B, HTR5A, PTGS2, TYR |
7.84244 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, HSD11B2, HTR1B, HTR5A, PTGS2, TYR |
7.8002 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, BCL2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, PTGS2 |
7.70759 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, TNKS, TNKS2, XDH |
7.63828 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
7.63828 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
7.63828 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, ALOX15, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, TNKS, TNKS2, XDH |
7.62003 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
7.38394 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
7.35932 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
7.2539 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
7.24899 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, HTR1B, HTR2A, PTGS2 |
7.24562 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, HTR1B, HTR2A, PTGS2 |
7.24562 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
7.15079 |
[BP] GO:0007198 |
None
|
HTR1A, HTR1B, HTR5A, HTR7 |
7.10954 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
7.01057 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.78169 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, FABP3, FABP4, FUT7, GBA2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
6.71041 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7 |
6.66068 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALDH2, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, GBA2, HTR1A, TYR |
6.66068 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
6.61264 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, CNR1, DRD1, DRD2, DRD3, HCAR2, PIK3CB, PTGS2, TNKS, TNKS2 |
6.41287 |
[BP] GO:0099536 |
None
|
CNR1, DRD1, DRD2, DRD3, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
6.26468 |
[BP] GO:0099537 |
None
|
CNR1, DRD1, DRD2, DRD3, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
6.26468 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.11628 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
6.06713 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX15, ALPL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRB, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, MMP1, MMP2, MMP9, PIK3CA, PPARA, PTGS2, TNKS2, TYR |
6.02581 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, CNR1, DRD2, DRD3, HTR1B, HTR2A, MMP9, PTGS2 |
5.9599 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, HTR1B, HTR5A, PPARA, PTGS2 |
5.93045 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, CNR1, DRD2, DRD3, HSD11B2, PPARA, PTGS1, PTGS2 |
5.76395 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.73601 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.73601 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.73601 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, HTR1A, HTR1B, HTR2A, HTR2B, MMP2, MMP9, PTGS1, PTGS2, XDH |
5.72095 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR2C |
5.69189 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
5.64223 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.43614 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, CNR1, DRD1, DRD2, DRD3, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.38908 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, DRD3, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.38134 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, DRD3, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.38134 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
5.37501 |
[BP] GO:0051952 |
None
|
ADORA1, CNR1, DRD1, DRD2, DRD3, HTR1B, HTR2A |
5.37501 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA, PTGS1, PTGS2 |
5.33371 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, TYR |
5.30834 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
5.30505 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX15, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
5.26553 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
5.24857 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
5.24239 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F3, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, TNKS, TNKS2, XDH |
5.18949 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, BCL2, CNR1, DRD1, DRD2, DRD3, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2 |
5.16121 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, HSD11B2, HTR1B, HTR5A, MMP2, PPARA, PTGS2 |
5.15712 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, ALPL, BCL2, CA2, CA6, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, TYR |
5.118 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F3, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, TNKS, TNKS2, XDH |
5.07513 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, F3, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, TNKS, TNKS2, XDH |
5.02745 |
[BP] GO:0007200 |
None
|
ADRA1A, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
5.02745 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, TNKS, TNKS2, XDH |
5.01711 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HTR1B, HTR1D |
5.01511 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, BCL2, CA1, CA2, CDK6, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTPN1, SIGMAR1, TNKS, TNKS2 |
4.89807 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR1B, HTR2B |
4.89407 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, CNR1, DRD1, DRD2, DRD3, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.87723 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, DRD3, HTR1B, HTR2A |
4.87723 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, HTR2C, TNKS, TNKS2 |
4.77453 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, ALOX15, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, DRD3, ESRRA, F3, FABP4, HTR2A, HTR2B, HTR2C, HTR6, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, TNKS, TNKS2, XDH |
4.73261 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, XDH |
4.6749 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3 |
4.65535 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.62186 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, XDH |
4.62186 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, DRD3, FABP3, HCAR2, HTR2A, HTR2B, HTR2C, PPARA, PTGS2 |
4.54732 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, BCL2, CYP1B1, DRD2, F3, HTR2A, HTR2B, HTR2C, HTR6, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
4.50641 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
4.49054 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
4.49054 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ALOX15, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
4.4891 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR1B, HTR2A |
4.4664 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.45588 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.43992 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, DRD3, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA, PTGS2, TYR |
4.38339 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, DRD3, ESR1, F3, HTR1A, HTR1B, HTR2A, HTR2B, MMP2, MMP9, PTGS2 |
4.37089 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, HTR2A, HTR2B, HTR2C, PIK3CB |
4.34039 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, NQO2, PTGS1 |
4.31039 |
[BP] GO:0032787 |
None
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GBA2, PPARA, PTGS1, PTGS2 |
4.28633 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, ALOX15, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FUT7, GBA2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
4.25412 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.24582 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3, PTGS2 |
4.24582 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, HTR2C, PPARA |
4.16026 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, PTGS2 |
4.16026 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
4.08742 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.08742 |
[BP] GO:0045776 |
None
|
ADORA1, CNR1, DRD2, DRD3, PPARA |
4.05828 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR1D, HTR2B |
4.04823 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, CNR1, DRD1, DRD2, DRD3, HTR1A, HTR1B, HTR2A, MMP9, PTGS2 |
4.04371 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FUT7, GBA2, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SIGMAR1, TNKS2, TYR |
4.0139 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, TNKS, TNKS2, XDH |
4.0139 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
3.90542 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
3.90456 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.87008 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, DRD3, HTR1B, HTR2A |
3.83847 |
[BP] GO:0032229 |
None
|
ADORA1, CNR2, HTR1B |
3.8226 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.80617 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD2, ESRRB, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
3.80573 |
[BP] GO:0007610 |
None
|
BCL2, CNR1, DRD1, DRD2, DRD3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, PPARA, PTGS2 |
3.80573 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, BCL2, CA2, CA7, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP9, PIK3CB, PPARA, PTGS2, PTPN1 |
3.80157 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, DRD3, HTR1B, HTR2A |
3.76694 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, HTR1A, HTR1B, HTR2C |
3.74491 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
3.74437 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, HSD11B2, HTR1B, HTR2A, HTR2B, MMP2, PPARA, PTGS2, TYR |
3.74397 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, BCL2, CA2, CA7, CNR1, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP9, PIK3CB, PPARA, PTGS2, PTPN1 |
3.68955 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, MMP9, PTGS2 |
3.65307 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
3.62584 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.61555 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.61482 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2, HSD11B2 |
3.59943 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.58387 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.55576 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR1B, HTR2B |
3.54262 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.5171 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2, DRD3 |
3.44977 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.44735 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.43815 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.43815 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, ALOX15, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, F3, FABP4, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, TNKS, TNKS2, XDH |
3.42083 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
3.41452 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.41205 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD2, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
3.40497 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, ESRRB, HTR1B, HTR1E, HTR2A, PPARA |
3.38107 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, XDH |
3.34586 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, PTGS2 |
3.32348 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, F3, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
3.3017 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, ESRRB, HTR1B, HTR1E, HTR2A, PPARA |
3.29526 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, HTR2C, PTGS2 |
3.25792 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B, HTR2C |
3.25792 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, ALDH2, AOX1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, GBA2, MMP1, MMP2, MMP9, PIK3CB, XDH |
3.25628 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.24964 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, BCL2, CYP19A1, ESR1 |
3.23946 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.23946 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.23946 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.22078 |
[BP] GO:0042220 |
None
|
CNR1, DRD2, DRD3, HTR1B |
3.19276 |
[BP] GO:0045777 |
None
|
ADORA1, ADRA1A, CNR1, HSD11B2 |
3.19276 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.19276 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
3.19276 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
BCL2, DRD2, DRD3, PIK3CA, TNKS2 |
3.18373 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
3.18115 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, GBA2, HSD11B1, HSD17B2, HTR5A, MMP9, PIK3CA, PPARA, PTGS2, SIGMAR1, TYR |
3.17464 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.17042 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, PIK3CA |
3.16181 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.14786 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD2, DRD3, FABP3, HSD11B2, HTR1B, MMP2, PPARA, PTGS2, TYR |
3.12555 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2 |
3.11235 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.10072 |
[BP] GO:1900543 |
None
|
DRD2, DRD3, HTR1B, HTR1E, PPARA |
3.08059 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, HTR2A, HTR2B, HTR2C, PPARA, PTGS2 |
3.0734 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CNR1, CYP19A1, DRD2, HCAR2, HTR1A, HTR2A, HTR2C |
3.07329 |
[BP] GO:0045980 |
None
|
DRD2, DRD3, HTR1B, HTR1E, PPARA |
3.05629 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2 |
3.02932 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.02081 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.99777 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
2.99035 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.96503 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALDH2, ALOX15, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FUT7, GBA2, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SIGMAR1, TNKS, TNKS2, TYR, XDH |
2.95588 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2 |
2.95555 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B, HTR2C |
2.95555 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, HSD11B1, HSD17B2, PIK3CA, PPARA, TYR |
2.94756 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CNR1, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C |
2.91799 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, ALOX15, BCL2, CDK6, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, ESR1, ESR2, MMP9, PPARA, PTGS2, PTPN1, XDH |
2.9019 |
[BP] GO:0014075 |
None
|
CNR2, DRD1, DRD2, DRD3 |
2.88398 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
2.8811 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.8811 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, HTR2A, HTR2B, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, TNKS, XDH |
2.8736 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.86219 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.86219 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.86219 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD2, DRD3, FABP3, HSD11B2, HTR1B, MMP2, PPARA, PTGS2, TYR |
2.82893 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, TNKS, TNKS2, XDH |
2.81007 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2 |
2.80658 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.78689 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD1, DRD2, FABP4, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
2.76867 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.76867 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD2, DRD3, HTR1B |
2.70877 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.70444 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.70444 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, HTR2A, HTR2B, HTR2C |
2.70444 |
[BP] GO:0060359 |
None
|
CNR1, DRD1, DRD2, DRD3, HTR1B |
2.69278 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.68436 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.68436 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CNR1, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C |
2.65028 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GBA2, PPARA, PTGS1, PTGS2, TYR |
2.64645 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.63798 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.63798 |
[BP] GO:0097366 |
None
|
CNR2, DRD1, DRD2, DRD3 |
2.63798 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.63501 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, ALOX15, DRD2, HTR2A, HTR2B, HTR2C, PIK3CB, PTPN1, XDH |
2.61921 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HCAR2, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, TNKS, TNKS2, XDH |
2.59455 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, BCL2, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR1B, HTR2A, MMP9, PTGS2, PTPN1, XDH |
2.59034 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, TNKS, TNKS2, XDH |
2.57707 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, BCL2, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR1B, HTR2A, MMP9, PTGS2, PTPN1, XDH |
2.57707 |
[BP] GO:0043112 |
None
|
ACHE, DRD2, DRD3, HTR1B, HTR2B |
2.55414 |
[BP] GO:0030815 |
None
|
DRD2, DRD3, HTR1B, HTR1E |
2.53834 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.50418 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, HTR1D, MMP9, PTGS2 |
2.50247 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, ESR1, FABP4, MMP9, PPARA, PTGS2, PTPN1, TNKS |
2.49003 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, CSNK2A1, DRD2, ESR1, F3, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
2.47681 |
[BP] GO:0030800 |
None
|
DRD2, DRD3, HTR1B, HTR1E |
2.47681 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.47416 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.47416 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.47416 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.47416 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.47416 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.46947 |
[BP] GO:0050994 |
None
|
ADORA1, CNR1, HCAR2, PPARA |
2.42299 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, HCAR2, HTR2B, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SIGMAR1, XDH |
2.42299 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.41809 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, PPARA, PTGS2 |
2.41809 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.40963 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
2.40963 |
[BP] GO:0007613 |
None
|
CNR1, DRD1, DRD2, HTR2A, PTGS2 |
2.37811 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.3723 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, HTR2C |
2.36898 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, HCAR2, HTR2B, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SIGMAR1, XDH |
2.35625 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.35001 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD2, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
2.34884 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.34884 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, HTR1A, PTGS2 |
2.34615 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, HCAR2, HTR2B, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SIGMAR1, XDH |
2.31253 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.29262 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.29157 |
[BP] GO:0072347 |
None
|
CNR1, DRD2, DRD3, HTR1B |
2.29157 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD2, ESR1, F3, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
2.27926 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GBA2, PPARA, PTGS1, PTGS2, TYR |
2.27296 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, CNR1, HCAR2, HTR2B, PIK3CA, PPARA |
2.27296 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, HTR2A, HTR2B, HTR2C |
2.24981 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
HTR1B, MMP2, MMP9 |
2.24209 |
[BP] GO:0050995 |
None
|
ADORA1, CNR1, HCAR2 |
2.24209 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.24209 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, ALDH2, CYP1A2, CYP2A6, CYP2D6 |
2.23835 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.23835 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, TNKS, TNKS2, XDH |
2.22715 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.22715 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.22715 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.22715 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.22715 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.22715 |
[BP] GO:0014827 |
None
|
HTR1D, HTR2B |
2.22715 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, TNKS, TNKS2, XDH |
2.22715 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GBA2, PPARA, PTGS1, PTGS2, TYR |
2.21719 |
[BP] GO:0030814 |
None
|
DRD1, DRD2, DRD3, HTR1B, HTR1E |
2.21719 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, ALOX15, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, TNKS, TNKS2, XDH |
2.21719 |
[BP] GO:0050890 |
None
|
ADORA1, CNR1, DRD1, DRD2, DRD3, HTR2A, PTGS2 |
2.20758 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
2.20758 |
[BP] GO:0051953 |
None
|
ADORA1, CNR1, DRD2 |
2.20758 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.20758 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.20758 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, DRD2, HTR2A, HTR2B, HTR2C, PTPN1 |
2.19322 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.18477 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.15709 |
[BP] GO:0032098 |
None
|
HTR2C, HTR4, PPARA |
2.15709 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.15709 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, DRD1, DRD2, DRD3, PPARA |
2.15067 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
2.13707 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, DRD2, HTR2A, HTR2B, HTR2C |
2.10823 |
[BP] GO:0048511 |
rhythmic process
|
BCL2, CSNK2A1, DRD2, DRD3, ESR1, HTR7, PPARA |
2.10658 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, ESR1, ESRRA, HTR5A, PTGS2 |
2.10033 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
2.09959 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.08637 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, BCL2, CNR1, DRD2, DRD3, HTR1B, HTR2A, MMP9, PTGS2 |
2.06936 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.06804 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, PPARA, PTGS2 |
2.06712 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2 |
2.04834 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HSD11B2, HTR1A, HTR2C, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1 |
2.04834 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.04834 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.04834 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.04834 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.04834 |
[BP] GO:0071502 |
None
|
HTR1B, HTR2B |
2.04834 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.04834 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.04834 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.02321 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, CA4, CNR1, CNR2, DRD1, DRD2, DRD3, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, SIGMAR1 |
5.24239 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALPL, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, F3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SIGMAR1, TYR |
5.16279 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALPL, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, F3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP2, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SIGMAR1, TNKS, TNKS2, TYR |
4.95811 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, SIGMAR1 |
4.30103 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGS1, PTGS2, SIGMAR1 |
4.17584 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALPL, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F3, GBA2, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP2, PIK3CA, PIK3CB, PTPN1 |
3.48385 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, ALOX15, CA2, CA4, CA9, CNR1, CNR2, DRD1, DRD2, DRD3, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PTGS2, SIGMAR1 |
3.23946 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGS1, PTGS2, PTPN1, SIGMAR1 |
3.08431 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALDH2, ALOX15, AOX1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2A, HTR4, HTR5A, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SIGMAR1, TNKS, TNKS2, TYR, XDH |
2.49219 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.766 |
[MF] GO:0004993 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.766 |
[MF] GO:0099589 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.766 |
[MF] GO:0043176 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.6285 |
[MF] GO:0051378 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.6285 |
[MF] GO:0008227 |
None
|
ADRA1A, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
15.9713 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NQO2, PPARA, PTPN1, TNKS, TYR, XDH |
15.502 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
14.5423 |
[MF] GO:0099528 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
14.4441 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
13.8836 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, MMP1, MMP2, MMP9, NQO2, PPARA, PTGS1, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
11.6677 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
11.0935 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
10.9178 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.9178 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.56503 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALDH2, ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
9.49383 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA, SIGMAR1 |
9.25623 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, CDK6, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA, SIGMAR1 |
8.57934 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.39682 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, SIGMAR1 |
8.1715 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA, SIGMAR1 |
8.14244 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NQO2, PPARA, PTPN1, TNKS |
7.87162 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA, SIGMAR1 |
7.30428 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
7.00525 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2, TYR |
6.78169 |
[MF] GO:0048037 |
cofactor binding
|
ALDH2, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B2, HSD17B1, NQO2, PTGS1, PTGS2, XDH |
6.76554 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, XDH |
6.66579 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, F3, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, SIGMAR1 |
6.34674 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, CNR1, CNR2, DRD1, DRD2, DRD3, F3, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, SIGMAR1 |
6.34674 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
6.28344 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
6.13359 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
6.02678 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
6.02581 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
5.85524 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
5.33058 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
4.94964 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.47336 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
4.45588 |
[MF] GO:0008144 |
drug binding
|
ACHE, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, DRD1, DRD2, DRD3, HTR1B, HTR2A, HTR2B, HTR2C, NQO2, PIK3CA, PIK3CB, PPARA, SIGMAR1 |
4.16026 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALPL, AOX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NQO2, PPARA, PTGS1, PTGS2, PTPN1, TNKS, TNKS2, TYR, XDH |
4.0502 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, ALDH2, AOX1, XDH |
3.97125 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
3.83847 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.76694 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.76694 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.41205 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.40153 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.28562 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.14457 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
2.94756 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.8811 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.8811 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.8811 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.8811 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
2.8811 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.86219 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.47416 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.47416 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.35001 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA |
2.34499 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.22715 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.04834 |